Celldex Therapeutics
Nasdaq CLDX · Hampton, NJ
Works in Dermatology · ENT · Genetic & rare · GI & liver · Hematology · Immunology · Metabolic & endocrine · Oncology · Renal & urogenital · Respiratory · Women's health
Celldex Therapeutics is a clinical trial sponsor based in Hampton, NJ, listed as Nasdaq CLDX. It has 7 active clinical trials with 3,832 planned participants, across 11 therapeutic areas. Since 2021 it has completed 11 trials and stopped 1 early.
Trial track record · since 2021
Financials · Nasdaq CLDX
Fundraising
Pipeline · 7 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Celldex Therapeutics
Celldex Therapeutics is lead sponsor of 7 active clinical trials on ClinicalTrials.gov, with 3,832 planned participants, in Dermatology, ENT, Genetic & rare, GI & liver and other areas. Since 2021 it has completed 11 trials and stopped 1 early.
Celldex Therapeutics is based in Hampton, NJ and is listed as Nasdaq CLDX. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Celldex Therapeutics; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-07.
Approve Suite is not affiliated with Celldex Therapeutics. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.